SenGenix, Inc. — Form D

SenGenix, Inc. of DURHAM, NC, a company, filed a Form D exempt-offering notice with the SEC on 2016-09-15. The offering totals $1.5M, of which $1.5M was reported sold. Industry: Biotechnology.

Offering

Filed: 2016-09-15
Form: D
Accession: 0001586429-16-000003
Industry: Biotechnology
Exemptions: 06b
Total offering: $1.5M
Amount sold: $1.5M
Investors: 11
Date of first sale: 2016-09-01
Security types: debt
Revenue range: Decline to Disclose
SEC file number: 021-270774

Issuer

Name: SenGenix, Inc.
CIK: 0001586429
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2012
Address: 1738 HILLANDALE ROAD, DURHAM, NC, 27705
Phone: 919-864-8693

Officers, directors & promoters (13)

Name	Role	Location
Ralph S Snyderman	Director	Morrisville, NC
Richard S Surwit	Director	Durham, NC
Richard S Surwit	Executive Officer	Durham, NC
Homme E Hellinga	Director	Durham, NC
Homme E Hellinga	Executive Officer	Durham, NC
Lawrence S Cohen	Director	Durham, NC
Lawrence S Cohen	Executive Officer	Durham, NC
Ralph E Snyderman	Director	Durham, NC
Sandra E Cummings	Director	Durham, NC
Sandra E Cummings	Executive Officer	Durham, NC
Homme S Hellinga	Director	Durham, NC
Sandra S Cummings	Director	Durham, NC
Sandra S Cummings	Executive Officer	Durham, NC

Other filings by this issuer (4)

Filed	Form	Offering	Sold
2017-10-16	D	$6.3M	$6.3M
2015-10-27	D	$1.5M	$1.1M
2014-07-07	D/A	$2.5M	$2.0M
2013-09-13	D	$1.5M	$450K

More